Allarity Therapeutics, Inc. (ALLR) bonds
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Allarity Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Allarity Therapeutics's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| Convertible Promissory Note Due To Novartis Convertible | 5.00% | $1.00M | $1.35M |
| Streeterville A1 Note | 9.00% | $10.93M | – |
| Streeterville B Note | 5.00% | $10.00M | – |
| Streeterville Note | – | – | $20.86M |
| The20243i Convertible Senior Promissory Notes Convertible at $210 a share | – | $660.00K | – |
| The20243i Convertible Senior Promissory Notes Convertible | 8.00% | – | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?